MSN Laboratories said it has received its clinical trial approval from the DGCI to perform a study on Molnupiravir capsules on mild to moderate Covid patients.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.